SARS-CoV2 in public spaces in West London, UK during COVID-19 pandemic.
COVID-19
infection control
respiratory infection
Journal
BMJ open respiratory research
ISSN: 2052-4439
Titre abrégé: BMJ Open Respir Res
Pays: England
ID NLM: 101638061
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
02
12
2022
accepted:
28
04
2023
medline:
22
5
2023
pubmed:
19
5
2023
entrez:
18
5
2023
Statut:
ppublish
Résumé
Spread of SARS-CoV2 by aerosol is considered an important mode of transmission over distances >2 m, particularly indoors. We determined whether SARS-CoV2 could be detected in the air of enclosed/semi-enclosed public spaces. Between March 2021 and December 2021 during the easing of COVID-19 pandemic restrictions after a period of lockdown, we used total suspended and size-segregated particulate matter (PM) samplers for the detection of SARS-CoV2 in hospitals wards and waiting areas, on public transport, in a university campus and in a primary school in West London. We collected 207 samples, of which 20 (9.7%) were positive for SARS-CoV2 using quantitative PCR. Positive samples were collected from hospital patient waiting areas, from hospital wards treating patients with COVID-19 using stationary samplers and from train carriages in London underground using personal samplers. Mean virus concentrations varied between 429 500 copies/m During a period of partial opening during the COVID-19 pandemic in London, we detected SARS-CoV2 RNA in the air of hospital waiting areas and wards and of London Underground train carriage. More research is needed to determine the transmission potential of SARS-CoV2 detected in the air.
Sections du résumé
BACKGROUND
Spread of SARS-CoV2 by aerosol is considered an important mode of transmission over distances >2 m, particularly indoors.
OBJECTIVES
We determined whether SARS-CoV2 could be detected in the air of enclosed/semi-enclosed public spaces.
METHODS AND ANALYSIS
Between March 2021 and December 2021 during the easing of COVID-19 pandemic restrictions after a period of lockdown, we used total suspended and size-segregated particulate matter (PM) samplers for the detection of SARS-CoV2 in hospitals wards and waiting areas, on public transport, in a university campus and in a primary school in West London.
RESULTS
We collected 207 samples, of which 20 (9.7%) were positive for SARS-CoV2 using quantitative PCR. Positive samples were collected from hospital patient waiting areas, from hospital wards treating patients with COVID-19 using stationary samplers and from train carriages in London underground using personal samplers. Mean virus concentrations varied between 429 500 copies/m
CONCLUSION
During a period of partial opening during the COVID-19 pandemic in London, we detected SARS-CoV2 RNA in the air of hospital waiting areas and wards and of London Underground train carriage. More research is needed to determine the transmission potential of SARS-CoV2 detected in the air.
Identifiants
pubmed: 37202121
pii: 10/1/e001574
doi: 10.1136/bmjresp-2022-001574
pmc: PMC10200905
pii:
doi:
Substances chimiques
RNA, Viral
0
Particulate Matter
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support from UKRI EPSRC COVID-19 rapid response grant number EP/V052462/1 for the submitted; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.
Références
Respir Res. 2021 Feb 26;22(1):73
pubmed: 33637076
J Aerosol Sci. 2021 Feb;152:105693
pubmed: 33078030
J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
Nature. 2020 Jun;582(7813):557-560
pubmed: 32340022
Proc Natl Acad Sci U S A. 2022 Jul 5;119(27):e2200109119
pubmed: 35763573
Eur J Clin Microbiol Infect Dis. 2021 May;40(5):905-919
pubmed: 33389262
Emerg Infect Dis. 2020 Jul;26(7):1628-1631
pubmed: 32240078
J Pers Med. 2021 May 19;11(5):
pubmed: 34069409
J Hazard Mater. 2022 Feb 5;423(Pt B):127243
pubmed: 34844361
Environ Sci Pollut Res Int. 2022 Feb;29(10):13905-13916
pubmed: 34599449
Environ Res. 2020 Sep;188:109754
pubmed: 32526492
PLoS One. 2019 Jul 11;14(7):e0219122
pubmed: 31295271
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32568661
Int J Infect Dis. 2020 Nov;100:476-482
pubmed: 32949774
Emerg Infect Dis. 2004 Feb;10(2):311-6
pubmed: 15030703
Environ Int. 2020 Jan;134:105188
pubmed: 31787325
Sci Rep. 2020 Jul 29;10(1):12732
pubmed: 32728118
Sci Total Environ. 2020 Nov 1;741:140396
pubmed: 32592974
Sci Total Environ. 2022 Feb 25;809:151137
pubmed: 34699823
Arch Virol. 2021 Oct;166(10):2825-2828
pubmed: 34302551
Sci Total Environ. 2023 Feb 1;858(Pt 1):159315
pubmed: 36283528
Environ Int. 2020 Jun;139:105730
pubmed: 32294574
Environ Pollut. 2018 Feb;233:483-493
pubmed: 29101891
Emerg Infect Dis. 2020 Jun;26(6):1266-1273
pubmed: 32160149
Int J Infect Dis. 2021 Jul;108:212-216
pubmed: 33901650
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):606-610
pubmed: 32407303
Sci Total Environ. 2021 Oct 1;789:147976
pubmed: 34058581
Environ Int. 2021 Feb;147:106326
pubmed: 33340987
Front Public Health. 2020 Nov 23;8:590041
pubmed: 33330334
Environ Res. 2022 Aug;211:113038
pubmed: 35231456
BMJ Open. 2018 Sep 28;8(9):e020362
pubmed: 30269061
Natl Sci Rev. 2020 Sep 28;7(12):1865-1867
pubmed: 34676084
J Clin Virol. 2020 Dec;133:104660
pubmed: 33126109
Nat Commun. 2020 May 29;11(1):2800
pubmed: 32472043
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Environ Sci Pollut Res Int. 2021 Aug;28(30):40460-40473
pubmed: 33630259